Microbes

Microbes is multidisciplinary international, open access, peer reviewed scientific journal committed to publish original research, critical reviews, and short communications, reporting theoretical, experimental, applied, and descriptive work in all aspects of microbial science.

Editor-in-Chief: Dr. Sajjad Hyder
Country of Publication: Pakistan
Format: Print & Online
Frequency: 03
Publication Dates: April, August, December
Language: English
Author Fees: Yes
Types of Journal: Academic/Scholarly Journal
Access: Open Access
Indexed & Abstracted: Yes
Policy: Double blind peer-reviewed
Review Time: 04-06 weeks approximately
Contact & Submission e-mail: microbes@esciencepress.net
Alternate e-mail: info@esciencepress.net


Microbes

Journal Scope

The journal aims to serve the research community by providing a platform for researchers to publish quality research in both fundamental and applied microbiology. The journal considers submissions on microbes infecting or interacting with microbes, plants, animals, and humans covering the following aspects:

  • Agricultural microbiology

  • Beneficial microbes

  • computational, systems, & synthetic microbiology

  • Environmental microbiology

  • Food microbiology

  • Industrial microbiology

  • Medical & pharmaceutical microbiology

  • Microbial physiology & ecology

  • Microbial biochemistry

  • Microbial genetics & genomics

  • Microbial biotechnology

  • veterinary microbiology

 

Microbes follow guidelines by Committee on Publication Ethics (COPE). Microbes takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. Microbes takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. Microbes works with PUBLONS to provide reviewers with credit for their work.

Latest News on Microbes

 

Oldest reconstructed bacterial genomes link farming, herding with emergence of new disease

Using Salmonella enterica genomes recovered from human skeletons as old as 6,500 years, an international team of researchers illustrates the evolution of a human pathogen and provides the first ancient DNA evidence in support of the hypothesis that the cultural transition from foraging to farming facilitated the emergence of human-adapted pathogens that persist until today.
Posted: 2020-02-24More...
 

New tool for an old disease: Use of PET and CT scans may help develop shorter TB treatment

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization reports that TB is still the leading cause of death worldwide from a single infectious agent, responsible for some 1.5 million fatalities annually.
Posted: 2020-02-24More...
 

Specific gut bacteria may be associated with pulmonary arterial hypertension

Researchers have found a specific bacterial profile in the gut of people with pulmonary arterial hypertension, a chronic and progressive disease that causes constriction of arteries in the lungs. The unique bacterial profile predicted pulmonary arterial hypertension with 83% accuracy.
Posted: 2020-02-24More...
 

Artificial intelligence yields new antibiotic

Using a machine-learning algorithm, researchers have identified a powerful new antibiotic compound. In laboratory tests, the drug killed many of the world's most problematic disease-causing bacteria, including some strains that are resistant to all known antibiotics. It also cleared infections in two different mouse models.
Posted: 2020-02-20More...
 

Research team tackles superbug infections with novel therapy

Superbug infections kill 35,000 people in the US annually. A team of researchers has found that a treatment known as AB569 kills pseudomonas aeruginosa in humanized cells in mouse models. The treatment does not harm these humanized cells.
Posted: 2020-02-20More...
 

Announcements

 
No announcements have been published.
 
More Announcements...